Jörg Thomalla

2.6k total citations · 1 hit paper
31 papers, 554 citations indexed

About

Jörg Thomalla is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Jörg Thomalla has authored 31 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 8 papers in Genetics. Recurrent topics in Jörg Thomalla's work include Chronic Lymphocytic Leukemia Research (8 papers), Advanced Breast Cancer Therapies (7 papers) and Cancer survivorship and care (7 papers). Jörg Thomalla is often cited by papers focused on Chronic Lymphocytic Leukemia Research (8 papers), Advanced Breast Cancer Therapies (7 papers) and Cancer survivorship and care (7 papers). Jörg Thomalla collaborates with scholars based in Germany, Switzerland and Estonia. Jörg Thomalla's co-authors include Rudolf Weide, Jochen Heymanns, H. Köppler, Sibylle Loibl, Andreas Schneeweiß, Claus Hanusch, Jens Huober, Jens‐Uwe Blohmer, Carsten Denkert and Michael Untch and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jörg Thomalla

29 papers receiving 542 citations

Hit Papers

Neoadjuvant durvalumab improves survival in early triple-... 2022 2026 2023 2024 2022 40 80 120
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response
    2022 136 citations Sibylle Loibl, Andreas Schneeweiß et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jörg Thomalla Germany 11 404 151 133 124 107 31 554
Michaela L. Tsai United States 17 561 1.4× 244 1.6× 200 1.5× 124 1.0× 31 0.3× 35 850
Emi Noguchi Japan 12 352 0.9× 120 0.8× 208 1.6× 61 0.5× 41 0.4× 63 608
Wolfgang Abenhardt Germany 10 230 0.6× 45 0.3× 118 0.9× 151 1.2× 156 1.5× 26 396
Gene Saylors United States 9 241 0.6× 34 0.2× 200 1.5× 118 1.0× 116 1.1× 14 426
Jacques Olivier Bay France 12 201 0.5× 80 0.5× 203 1.5× 77 0.6× 69 0.6× 30 474
Benjamin M. Parsons United States 12 204 0.5× 90 0.6× 90 0.7× 252 2.0× 68 0.6× 36 440
Anthea Lau Canada 9 158 0.4× 48 0.3× 154 1.2× 105 0.8× 127 1.2× 28 413
Anja Welt Germany 13 457 1.1× 218 1.4× 213 1.6× 51 0.4× 49 0.5× 42 639
Manuela Zanni Italy 11 376 0.9× 189 1.3× 63 0.5× 639 5.2× 178 1.7× 35 713
H. S. Hochster United States 12 430 1.1× 45 0.3× 130 1.0× 112 0.9× 62 0.6× 21 517

Countries citing papers authored by Jörg Thomalla

Since Specialization
Citations

This map shows the geographic impact of Jörg Thomalla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörg Thomalla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörg Thomalla more than expected).

Fields of papers citing papers by Jörg Thomalla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jörg Thomalla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörg Thomalla. The network helps show where Jörg Thomalla may publish in the future.

Co-authorship network of co-authors of Jörg Thomalla

This figure shows the co-authorship network connecting the top 25 collaborators of Jörg Thomalla. A scholar is included among the top collaborators of Jörg Thomalla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jörg Thomalla. Jörg Thomalla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lutz, Christoph, et al.. (2023). Patients with indolent lymphomas are at high risk of infections: experience from a German outpatient clinic. BMC Immunology. 24(1). 2–2. 2 indexed citations
3.
Loibl, Sibylle, Andreas Schneeweiß, Jens Huober, et al.. (2022). Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response. Annals of Oncology. 33(11). 1149–1158. 136 indexed citations breakdown →
4.
5.
Loibl, Sibylle, Michael Untch, Nicole Burchardi, et al.. (2018). Randomized phase II neoadjuvant study (GeparNuevo) to investigate the addition of durvalumab to a taxane-anthracycline containing chemotherapy in triple negative breast cancer (TNBC).. Journal of Clinical Oncology. 36(15_suppl). 104–104. 43 indexed citations
6.
Loibl, Sibylle, Michael Untch, Nicole Burchardi, et al.. (2017). A randomized phase II neoadjuvant study (GeparNuevo) to investigate the addition of durvalumab, a PD-L1 antibody, to a taxane-anthracycline containing chemotherapy in triple negative breast cancer (TNBC).. Journal of Clinical Oncology. 35(15_suppl). 3062–3062. 10 indexed citations
7.
Heymanns, Jochen, et al.. (2016). Follow-up Reality for Breast Cancer Patients – Standardised Survey of Patients and Physicians and Analysis of Treatment Data. Geburtshilfe und Frauenheilkunde. 76(5). 557–563. 9 indexed citations
8.
Weide, Rudolf, et al.. (2016). Adherence assessment of patients with metastatic solid tumors who are treated in an oncology group practice. SpringerPlus. 5(1). 270–270. 5 indexed citations
9.
Weide, Rudolf, et al.. (2015). Outpatient Management of Patients with Immune Thrombocytopenia (ITP) by Hematologists 1995-2014. Oncology Research and Treatment. 39(1-2). 41–44. 14 indexed citations
10.
Weide, Rudolf, et al.. (2014). Metastatic breast cancer: prolongation of survival in routine care is restricted to hormone-receptor- and Her2-positive tumors. SpringerPlus. 3(1). 535–535. 34 indexed citations
11.
Heymanns, Jochen, et al.. (2014). Breast Cancer Morbidity. Deutsches Ärzteblatt international. 111(31-32). 537–44. 25 indexed citations
12.
13.
14.
15.
16.
Heymanns, Jochen, et al.. (2010). Evaluation of psychosocial distress in patients treated in a community-based oncology group practice in Germany. Annals of Oncology. 22(4). 931–938. 26 indexed citations
17.
18.
19.
Weide, Rudolf, et al.. (2007). Ovarian Cancer Treatment Reality in Northern Rheinland- Pfalz (Germany). Suboptimal Surgical Treatment as a Possible Cause for Inferior Survival. Oncology Research and Treatment. 30(12). 611–617. 6 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michaela L. Tsai Breakdown of academic impact, for papers by Emi Noguchi Breakdown of academic impact, for papers by Wolfgang Abenhardt Breakdown of academic impact, for papers by Gene Saylors Breakdown of academic impact, for papers by Jacques Olivier Bay Breakdown of academic impact, for papers by Benjamin M. Parsons Breakdown of academic impact, for papers by Anthea Lau Breakdown of academic impact, for papers by Anja Welt Breakdown of academic impact, for papers by Manuela Zanni Breakdown of academic impact, for papers by H. S. Hochster
Rankless by CCL
2026